Ranolazine in the treatment of chronic stable angina

被引：0

作者：

Gustapane, M. ^{[1
]}

Cardillo, M. T. ^{[1
]}

Biasillo, G. ^{[1
]}

Della Bona, R. ^{[1
]}

机构：

[1] Univ Cattolica Sacro Cuore, Ist Cardiol, Pol A Gemelli, I-00168 Rome, Italy

来源：

CLINICA TERAPEUTICA | 2012年 / 163卷 / 03期

关键词：

chronic stable angina; coronary artery disease; ranolazine; LATE SODIUM CURRENT; RAT HEARTS; ISCHEMIC-MYOCARDIUM; EXERCISE TOLERANCE; CONTROLLED-TRIAL; INHIBITION; DILTIAZEM; PECTORIS; PHARMACOKINETICS; AMLODIPINE;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Coronary artery disease is the leading cause of death in Europe and in the US and angina is the most common symptom associated with stable coronary artery disease. Despite receiving optimal antianginal therapy, based on agents such as beta-blockers, calcium channel antagonists and nitrates, many patients continue to experience angina. Furthermore, the administration of these drugs is limited by adverse effects such as bradycardia or hypotension. Ranolazine is a new antianginal agent, recently approved as add-on therapy in patients with stable angina. This review will focus on its mechanism of action, tolerability, highlighting the clinical benefit coming from its use. Clin Ter 2012; 163(3):231-234

引用

页码：231 / 234

页数：4

共 50 条

[41] Effects of Ranolazine on Left Ventricular Diastolic and Systolic Function in Patients with Chronic Coronary Disease and Stable Angina
Babalis, Dimitrios
Tritakis, Vlassis
Floros, Georgios
Mouzarou, Aggeliki
Kafkas, Nikolaos
Bampali, Konstantina
Mertzanos, Georgios
HELLENIC JOURNAL OF CARDIOLOGY, 2015, 56 (03) : 237 - 241
[42] Should ranolazine be used for all patients with ischemic heart disease or only for symptomatic patients with stable angina or for those with refractory angina pectoris? A critical appraisal
Thadani, Udho
EXPERT OPINION ON PHARMACOTHERAPY, 2012, 13 (17) : 2555 - 2563
[43] Pharmacologic management of chronic stable angina
Dixit, Deepali
Kimborowicz, Katarzyna
JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2015, 28 (06):
[44] Chronic Stable Angina
Ohman, E. Magnus
NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (12) : 1167 - 1176
[45] Management of Chronic Stable Angina
Walters, Michele Ann
CRITICAL CARE NURSING CLINICS OF NORTH AMERICA, 2017, 29 (04) : 487 - +
[46] Ranolazine for the treatment of refractory angina in a veterans population
Greene, R. Shane
Rangel, Robert M.
Edwards, Krystal L.
Chastain, Lisa M.
Brouse, Sara D.
Alvarez, Carlos A.
Collins, Laura J.
Brilakis, Emmanouil S.
Banerjee, Subhash
CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2012, 13 (02) : 141.e1 - 141.e5
[47] ANGINA Ivabradine for treatment of stable angina pectoris
de Silva, Ranil
Fox, Kim M.
NATURE REVIEWS CARDIOLOGY, 2009, 6 (05) : 329 - 330
[48] Review of the If selective channel inhibitor ivabradine in the treatment of chronic stable angina
Prasad, Usha K.
Gray, David
Purcell, Henry
ADVANCES IN THERAPY, 2009, 26 (02) : 127 - 137
[49] Cost-utility of Ranolazine for Chronic Stable Angina Pectoris: Systematic Review and Meta-analysis
Ayyasamy, Lavanya
Bagepally, Bhavani Shankara
CLINICAL THERAPEUTICS, 2023, 45 (05) : 458 - 465
[50] Effects of ranolazine on various outcomes in patients with stable angina: an updated meta-analysis
Manolis, Athanasios
Kallistratos, Manolis
Poulimenos, Leonidas
Zamfir, Tatiana
Thomopoulos, Costas
HELLENIC JOURNAL OF CARDIOLOGY, 2023, 71 : 26 - 32

← 1 2 3 4 5 →